SCHEMBL1770626

SCHEMBL1770626

CCC/C=C/COC(=O)CC(C)C

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.36
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
TSHR P16473 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
DGKA P23743 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1770629 1.00 PRKCA (0.36) PRKCAMMP1MMP2MMP3MMP9
SCHEMBL2036048 0.93 PRKCA (0.35) PRKCATDP1ALDH1A1
SCHEMBL28766201 0.89 F7 (0.41) PRKCADGKAALDH1A1
SCHEMBL28588909 0.89 F7 (0.41) PRKCADGKAALDH1A1
SCHEMBL17075354 0.85 PRKCA (0.37) PRKCAMMP1MMP2MMP3MMP9
SCHEMBL17075355 0.85 PRKCA (0.37) PRKCAMMP1MMP2MMP3MMP9
SCHEMBL5898821 0.82 MME (0.32)
SCHEMBL5898822 0.82 MME (0.32)
SCHEMBL873462 0.80 NAAA (0.42) TSHRTDP1DGKATAS1R3TAS1R1
SCHEMBL2039597 0.80 NAAA (0.42) TSHRTDP1DGKATAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708570-A2 COMPOSITION AND USE THEREOF AS ATTRACTANT FOR THE GARDEN CHAFER i (PHYLLOPERTHA HORTICOLA) /i Freie Universität Berlin (DE) 2006-10-11 EP claimed
WO-2005072526-A2 COMPOSITION AND USE THEREOF AS ATTRACTANT FOR THE GARDEN CHAFER (PHYLLOPERTHA HORTICOLA) FREIE UNIVERSITÄT BERLIN (DE) 2005-08-11 WO claimed
EP-4435080-B1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE (US) 2025-08-20 EP disclosed
US-12371642-B2 Benefit agent containing delivery particle THE PROCTER & GAMBLE COMPANY (US) 2025-07-29 US disclosed
EP-3955900-B1 POLYMERIC CAPSULES PROCTER & GAMBLE (US) 2025-07-23 EP disclosed
US-20240316523-A1 PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE PROCTER & GAMBLE COMPANY, THE 2024-09-26 US disclosed
EP-4435080-A1 A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE The Procter & Gamble Company (US) 2024-09-25 EP disclosed
EP-3596192-B1 BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES PROCTER & GAMBLE (US) 2024-05-15 EP disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
CN-117426473-A Preparation method of salix mongolica water extract, preparation method of salix mongolica flavor seasoning and application of salix mongolica flavor seasoning 黄山学院 2024-01-23 CN disclosed
US-20230313084-A1 BENEFIT AGENT CONTAINING DELIVERY PARTICLE PROCTER & GAMBLE (US) 2023-10-05 US disclosed
US-20130039962-A1 ENCAPSULATES ENCAPSYS, LLC 2013-02-14 US disclosed
EP-2468239-A1 Encapsulates Procter & Gamble International Operations SA (CH) 2012-06-27 EP disclosed
US-20120152268-A1 ENCAPSULATES PROCTER & GAMBLE COMPANY, THE 2012-06-21 US disclosed
US-20110152147-A1 ENCAPSULATES PROCTER & GAMBLE COMPANY, THE 2011-06-23 US disclosed
US-20110152146-A1 ENCAPSULATES THE PROCTER & GAMBLE COMPANY 2011-06-23 US disclosed
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES THE PROCTER & GAMBLE COMPANY 2011-05-12 US disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed
EP-1708570-A2 COMPOSITION AND USE THEREOF AS ATTRACTANT FOR THE GARDEN CHAFER i (PHYLLOPERTHA HORTICOLA) /i Freie Universität Berlin (DE) 2006-10-11 EP disclosed
WO-2005072526-A2 COMPOSITION AND USE THEREOF AS ATTRACTANT FOR THE GARDEN CHAFER (PHYLLOPERTHA HORTICOLA) FREIE UNIVERSITÄT BERLIN (DE) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 PRKCA 2722/4885MMP1 4672/4885MMP2 4489/4885
US-20130039962-A1 ENCAPSULATES ABCB4, PPIB, FLNB PRKCA 4376/4885MMP1 2347/4885MMP2 4269/4885
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES PLIN5, PORCN, PIGS PRKCA 3328/4885MMP1 1083/4885MMP2 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.